

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 9.39212076 |
| 2 | DNA deamination (GO:0045006) | 9.25297804 |
| 3 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 9.10565419 |
| 4 | T cell migration (GO:0072678) | 6.09929273 |
| 5 | monocyte chemotaxis (GO:0002548) | 6.01318604 |
| 6 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 5.98931725 |
| 7 | positive thymic T cell selection (GO:0045059) | 5.97011274 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.69770608 |
| 9 | negative regulation of B cell proliferation (GO:0030889) | 5.65788953 |
| 10 | positive regulation of B cell differentiation (GO:0045579) | 5.42343522 |
| 11 | regulation of T cell tolerance induction (GO:0002664) | 5.40136356 |
| 12 | positive T cell selection (GO:0043368) | 5.32572403 |
| 13 | positive regulation of tolerance induction (GO:0002645) | 5.28254295 |
| 14 | actin nucleation (GO:0045010) | 5.10103795 |
| 15 | negative T cell selection (GO:0043383) | 5.02620198 |
| 16 | negative thymic T cell selection (GO:0045060) | 4.97442199 |
| 17 | regulation of B cell differentiation (GO:0045577) | 4.78131241 |
| 18 | thymic T cell selection (GO:0045061) | 4.54116163 |
| 19 | regulation of tolerance induction (GO:0002643) | 4.50781757 |
| 20 | pyrimidine nucleoside catabolic process (GO:0046135) | 4.45927835 |
| 21 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.45673844 |
| 22 | regulation of regulatory T cell differentiation (GO:0045589) | 4.44397530 |
| 23 | regulation of activation of Janus kinase activity (GO:0010533) | 4.42732469 |
| 24 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.42576191 |
| 25 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 4.41118606 |
| 26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.40982416 |
| 27 | negative regulation of viral genome replication (GO:0045071) | 4.25758281 |
| 28 | negative regulation by host of viral transcription (GO:0043922) | 4.23326115 |
| 29 | negative regulation of B cell activation (GO:0050869) | 4.22001815 |
| 30 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.20022868 |
| 31 | dendritic cell chemotaxis (GO:0002407) | 4.17238258 |
| 32 | intestinal epithelial cell development (GO:0060576) | 4.16779014 |
| 33 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.14775601 |
| 34 | cellular response to interleukin-15 (GO:0071350) | 4.13963103 |
| 35 | regulation of T cell chemotaxis (GO:0010819) | 4.07711129 |
| 36 | positive regulation of T cell chemotaxis (GO:0010820) | 4.07711129 |
| 37 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.07327128 |
| 38 | eosinophil chemotaxis (GO:0048245) | 4.05038423 |
| 39 | mast cell activation (GO:0045576) | 4.05036417 |
| 40 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.01518904 |
| 41 | regulation of chronic inflammatory response (GO:0002676) | 3.97959236 |
| 42 | adaptation of signaling pathway (GO:0023058) | 3.96211970 |
| 43 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.92535042 |
| 44 | T cell mediated immunity (GO:0002456) | 3.91934788 |
| 45 | T cell selection (GO:0045058) | 3.91915785 |
| 46 | positive regulation of defense response to virus by host (GO:0002230) | 3.86381643 |
| 47 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.86149398 |
| 48 | T cell costimulation (GO:0031295) | 3.82298628 |
| 49 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.78965140 |
| 50 | negative regulation of cell killing (GO:0031342) | 3.78965140 |
| 51 | lymphocyte costimulation (GO:0031294) | 3.77555947 |
| 52 | T cell receptor signaling pathway (GO:0050852) | 3.77035295 |
| 53 | negative regulation of T cell apoptotic process (GO:0070233) | 3.71855022 |
| 54 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.71098399 |
| 55 | negative regulation of macroautophagy (GO:0016242) | 3.70852587 |
| 56 | macrophage chemotaxis (GO:0048246) | 3.69294999 |
| 57 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.66853502 |
| 58 | eosinophil migration (GO:0072677) | 3.66543528 |
| 59 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.59881617 |
| 60 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.59881617 |
| 61 | interferon-gamma production (GO:0032609) | 3.58957087 |
| 62 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.54063863 |
| 63 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.49978526 |
| 64 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.47544785 |
| 65 | mast cell activation involved in immune response (GO:0002279) | 3.44543698 |
| 66 | mast cell degranulation (GO:0043303) | 3.44543698 |
| 67 | response to interleukin-15 (GO:0070672) | 3.42688630 |
| 68 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.41921907 |
| 69 | positive regulation of interleukin-4 production (GO:0032753) | 3.41145645 |
| 70 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.40343407 |
| 71 | dendritic cell migration (GO:0036336) | 3.39751887 |
| 72 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.37866692 |
| 73 | lymphocyte migration (GO:0072676) | 3.35843818 |
| 74 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.30324271 |
| 75 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.29963043 |
| 76 | lymphocyte chemotaxis (GO:0048247) | 3.22423801 |
| 77 | positive regulation of lymphocyte migration (GO:2000403) | 3.22244803 |
| 78 | negative regulation of organelle assembly (GO:1902116) | 3.21693693 |
| 79 | regulation of viral genome replication (GO:0045069) | 3.20427208 |
| 80 | regulation of gamma-delta T cell activation (GO:0046643) | 3.17956317 |
| 81 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.15950443 |
| 82 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.14205751 |
| 83 | hepatocyte apoptotic process (GO:0097284) | 3.13614705 |
| 84 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.12562630 |
| 85 | activated T cell proliferation (GO:0050798) | 3.11430558 |
| 86 | chemokine-mediated signaling pathway (GO:0070098) | 3.10550947 |
| 87 | leukocyte aggregation (GO:0070486) | 3.09989784 |
| 88 | regulation of defense response to virus by host (GO:0050691) | 3.07060368 |
| 89 | regulation of calcium-mediated signaling (GO:0050848) | 3.06410170 |
| 90 | positive regulation of granulocyte differentiation (GO:0030854) | 3.03172049 |
| 91 | regulation of macrophage chemotaxis (GO:0010758) | 3.02293535 |
| 92 | B cell receptor signaling pathway (GO:0050853) | 3.01124783 |
| 93 | positive regulation of cell killing (GO:0031343) | 2.98369710 |
| 94 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.96679435 |
| 95 | DNA demethylation (GO:0080111) | 2.89904888 |
| 96 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.88429931 |
| 97 | regulation of cell killing (GO:0031341) | 2.82190767 |
| 98 | cytidine deamination (GO:0009972) | 10.3560994 |
| 99 | cytidine metabolic process (GO:0046087) | 10.3560994 |
| 100 | cytidine catabolic process (GO:0006216) | 10.3560994 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.98396042 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.61588154 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.30198680 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.07740779 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.96675413 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.62595655 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 4.40161854 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.14644045 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.82889235 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.47869467 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.34262818 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 3.24778660 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.81592879 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.80160745 |
| 15 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.65386868 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.58310605 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.31991244 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.27199360 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.23030615 |
| 20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.16028741 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.07886791 |
| 22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.03603750 |
| 23 | GATA3_26560356_Chip-Seq_TH2_Human | 2.02983778 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.94086818 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85912107 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75544788 |
| 27 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.65467044 |
| 28 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.64954452 |
| 29 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.62199792 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 1.60687271 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.59011078 |
| 32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.58705002 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.55478955 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.52152630 |
| 35 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.50791513 |
| 36 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.47754459 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47089596 |
| 38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.46616470 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43156081 |
| 40 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.38658659 |
| 41 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.34094579 |
| 42 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.32098779 |
| 43 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.30656470 |
| 44 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.24111271 |
| 45 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21084071 |
| 46 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.19643698 |
| 47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.18684435 |
| 48 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.15469508 |
| 49 | MAF_26560356_Chip-Seq_TH2_Human | 1.14565678 |
| 50 | GATA3_26560356_Chip-Seq_TH1_Human | 1.13370815 |
| 51 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.06573287 |
| 52 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.00472915 |
| 53 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97426220 |
| 54 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.97235454 |
| 55 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97074470 |
| 56 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.95465665 |
| 57 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.95083501 |
| 58 | TP53_16413492_ChIP-PET_HCT116_Human | 0.94830714 |
| 59 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.92808023 |
| 60 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89651319 |
| 61 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.89523419 |
| 62 | SPI1_23127762_ChIP-Seq_K562_Human | 0.89136773 |
| 63 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88334427 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87803144 |
| 65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.87067586 |
| 66 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.86661000 |
| 67 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85430347 |
| 68 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84318940 |
| 69 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.83945250 |
| 70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83445210 |
| 71 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83074011 |
| 72 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82221966 |
| 73 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.81593112 |
| 74 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.81314279 |
| 75 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81287333 |
| 76 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.80017822 |
| 77 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.79623272 |
| 78 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77405223 |
| 79 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.76086298 |
| 80 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.75451927 |
| 81 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.73934223 |
| 82 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.73605761 |
| 83 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.73353232 |
| 84 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.72791222 |
| 85 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71808388 |
| 86 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.71348544 |
| 87 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.71253906 |
| 88 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.69436111 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.68702382 |
| 90 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67854472 |
| 91 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.67651014 |
| 92 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.67566348 |
| 93 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.67403153 |
| 94 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.66673574 |
| 95 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.66264443 |
| 96 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.66106410 |
| 97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.65819906 |
| 98 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.64425558 |
| 99 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.64210151 |
| 100 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.63240576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.54196806 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.29318220 |
| 3 | MP0003183_abnormal_peptide_metabolism | 3.17634280 |
| 4 | MP0009785_altered_susceptibility_to | 3.10622012 |
| 5 | MP0009333_abnormal_splenocyte_physiolog | 3.04645134 |
| 6 | MP0000372_irregular_coat_pigmentation | 3.00430470 |
| 7 | MP0001800_abnormal_humoral_immune | 2.97264342 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.92569331 |
| 9 | MP0003011_delayed_dark_adaptation | 2.81541572 |
| 10 | MP0003045_fibrosis | 2.67494191 |
| 11 | MP0001188_hyperpigmentation | 2.59993761 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.58603735 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.57507090 |
| 14 | MP0004381_abnormal_hair_follicle | 2.56198909 |
| 15 | MP0001819_abnormal_immune_cell | 2.52127176 |
| 16 | MP0002405_respiratory_system_inflammati | 2.50056379 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.46511256 |
| 18 | MP0002723_abnormal_immune_serum | 2.44884322 |
| 19 | MP0000716_abnormal_immune_system | 2.37352286 |
| 20 | MP0002398_abnormal_bone_marrow | 2.35572803 |
| 21 | MP0001873_stomach_inflammation | 2.35299839 |
| 22 | MP0005025_abnormal_response_to | 2.35190005 |
| 23 | MP0000685_abnormal_immune_system | 2.34881245 |
| 24 | MP0000703_abnormal_thymus_morphology | 2.26290150 |
| 25 | MP0001853_heart_inflammation | 2.25102864 |
| 26 | MP0002452_abnormal_antigen_presenting | 2.18443900 |
| 27 | MP0003866_abnormal_defecation | 2.02011608 |
| 28 | MP0001790_abnormal_immune_system | 1.89118786 |
| 29 | MP0005387_immune_system_phenotype | 1.89118786 |
| 30 | MP0002722_abnormal_immune_system | 1.81430036 |
| 31 | MP0002429_abnormal_blood_cell | 1.79097345 |
| 32 | MP0003448_altered_tumor_morphology | 1.71251058 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.69648713 |
| 34 | MP0002419_abnormal_innate_immunity | 1.66405642 |
| 35 | MP0002006_tumorigenesis | 1.62815888 |
| 36 | MP0005310_abnormal_salivary_gland | 1.62067163 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.61279760 |
| 38 | MP0003436_decreased_susceptibility_to | 1.59611479 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.58546085 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.50333931 |
| 41 | MP0002163_abnormal_gland_morphology | 1.47199054 |
| 42 | MP0006082_CNS_inflammation | 1.42675978 |
| 43 | MP0005075_abnormal_melanosome_morpholog | 1.39459741 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.38762294 |
| 45 | MP0002019_abnormal_tumor_incidence | 1.34067727 |
| 46 | MP0002396_abnormal_hematopoietic_system | 1.30435018 |
| 47 | MP0001919_abnormal_reproductive_system | 1.30065345 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.30034240 |
| 49 | MP0000569_abnormal_digit_pigmentation | 1.29192966 |
| 50 | MP0003724_increased_susceptibility_to | 1.25552332 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.22980497 |
| 52 | MP0002933_joint_inflammation | 1.19401237 |
| 53 | MP0010307_abnormal_tumor_latency | 1.19303657 |
| 54 | MP0009763_increased_sensitivity_to | 1.08040005 |
| 55 | MP0004145_abnormal_muscle_electrophysio | 1.07582910 |
| 56 | MP0002877_abnormal_melanocyte_morpholog | 1.07385443 |
| 57 | MP0001984_abnormal_olfaction | 1.05067976 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.03910833 |
| 59 | MP0009379_abnormal_foot_pigmentation | 1.02555542 |
| 60 | MP0003786_premature_aging | 0.99686575 |
| 61 | MP0004134_abnormal_chest_morphology | 0.99562861 |
| 62 | MP0008789_abnormal_olfactory_epithelium | 0.98713705 |
| 63 | MP0000858_altered_metastatic_potential | 0.96009409 |
| 64 | MP0008007_abnormal_cellular_replicative | 0.95628762 |
| 65 | MP0008873_increased_physiological_sensi | 0.95071261 |
| 66 | MP0008260_abnormal_autophagy | 0.87645063 |
| 67 | MP0005389_reproductive_system_phenotype | 0.83912935 |
| 68 | MP0000920_abnormal_myelination | 0.81244433 |
| 69 | MP0002168_other_aberrant_phenotype | 0.81069468 |
| 70 | MP0000490_abnormal_crypts_of | 0.80772732 |
| 71 | MP0005379_endocrine/exocrine_gland_phen | 0.80336076 |
| 72 | MP0001905_abnormal_dopamine_level | 0.79616836 |
| 73 | MP0005499_abnormal_olfactory_system | 0.78418471 |
| 74 | MP0005394_taste/olfaction_phenotype | 0.78418471 |
| 75 | MP0002638_abnormal_pupillary_reflex | 0.74350657 |
| 76 | MP0009765_abnormal_xenobiotic_induced | 0.73786479 |
| 77 | MP0005623_abnormal_meninges_morphology | 0.72567679 |
| 78 | MP0004947_skin_inflammation | 0.72451558 |
| 79 | MP0005408_hypopigmentation | 0.70784412 |
| 80 | MP0000465_gastrointestinal_hemorrhage | 0.70719093 |
| 81 | MP0001533_abnormal_skeleton_physiology | 0.66793992 |
| 82 | MP0002693_abnormal_pancreas_physiology | 0.66621354 |
| 83 | MP0001958_emphysema | 0.66466967 |
| 84 | MP0009643_abnormal_urine_homeostasis | 0.63820093 |
| 85 | MP0003567_abnormal_fetal_cardiomyocyte | 0.61303579 |
| 86 | MP0002277_abnormal_respiratory_mucosa | 0.60536055 |
| 87 | MP0008469_abnormal_protein_level | 0.59670653 |
| 88 | MP0000639_abnormal_adrenal_gland | 0.58705305 |
| 89 | MP0005360_urolithiasis | 0.58627826 |
| 90 | MP0005645_abnormal_hypothalamus_physiol | 0.56350088 |
| 91 | MP0006035_abnormal_mitochondrial_morpho | 0.55957487 |
| 92 | MP0001765_abnormal_ion_homeostasis | 0.55676516 |
| 93 | MP0006276_abnormal_autonomic_nervous | 0.54457153 |
| 94 | MP0000733_abnormal_muscle_development | 0.53301111 |
| 95 | MP0009840_abnormal_foam_cell | 0.52432808 |
| 96 | MP0001191_abnormal_skin_condition | 0.52320706 |
| 97 | MP0005166_decreased_susceptibility_to | 0.51766970 |
| 98 | MP0002136_abnormal_kidney_physiology | 0.51511310 |
| 99 | MP0000604_amyloidosis | 0.50692746 |
| 100 | MP0001186_pigmentation_phenotype | 0.49375739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 9.08477570 |
| 2 | Abnormality of T cell number (HP:0011839) | 8.21171942 |
| 3 | Abnormality of T cells (HP:0002843) | 5.25954167 |
| 4 | Severe combined immunodeficiency (HP:0004430) | 4.59738957 |
| 5 | Autoimmune hemolytic anemia (HP:0001890) | 4.39060431 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.99665385 |
| 7 | IgG deficiency (HP:0004315) | 3.94858120 |
| 8 | Recurrent bronchitis (HP:0002837) | 3.93447088 |
| 9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.91193887 |
| 10 | Dysautonomia (HP:0002459) | 3.89270661 |
| 11 | Recurrent cutaneous fungal infections (HP:0011370) | 3.83912365 |
| 12 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.83912365 |
| 13 | Combined immunodeficiency (HP:0005387) | 3.79153799 |
| 14 | Thyroiditis (HP:0100646) | 3.69211962 |
| 15 | Hypoplasia of the thymus (HP:0000778) | 3.52541890 |
| 16 | Abnormality of the prostate (HP:0008775) | 3.50646587 |
| 17 | Agammaglobulinemia (HP:0004432) | 3.47950224 |
| 18 | Recurrent viral infections (HP:0004429) | 3.47888931 |
| 19 | Aplastic anemia (HP:0001915) | 3.28915406 |
| 20 | 3-Methylglutaconic aciduria (HP:0003535) | 3.28564342 |
| 21 | Chronic diarrhea (HP:0002028) | 3.25011007 |
| 22 | Meningitis (HP:0001287) | 3.24760971 |
| 23 | Hypoproteinemia (HP:0003075) | 3.19169030 |
| 24 | Panhypogammaglobulinemia (HP:0003139) | 3.17609441 |
| 25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.14770747 |
| 26 | Obstructive lung disease (HP:0006536) | 3.14770747 |
| 27 | Menstrual irregularities (HP:0000858) | 3.10058553 |
| 28 | Encephalitis (HP:0002383) | 3.03910730 |
| 29 | Lymphopenia (HP:0001888) | 3.03329508 |
| 30 | Retrobulbar optic neuritis (HP:0100654) | 2.94859149 |
| 31 | Optic neuritis (HP:0100653) | 2.94859149 |
| 32 | Orthostatic hypotension (HP:0001278) | 2.91463719 |
| 33 | Abnormality of eosinophils (HP:0001879) | 2.84829764 |
| 34 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.84069757 |
| 35 | Chest pain (HP:0100749) | 2.79294923 |
| 36 | Myositis (HP:0100614) | 2.76688578 |
| 37 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.74684704 |
| 38 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.74684704 |
| 39 | Pulmonary infiltrates (HP:0002113) | 2.72597573 |
| 40 | Recurrent fungal infections (HP:0002841) | 2.68745380 |
| 41 | Gangrene (HP:0100758) | 2.68179540 |
| 42 | Ureteral stenosis (HP:0000071) | 2.66091223 |
| 43 | Vasculitis (HP:0002633) | 2.65002138 |
| 44 | Ureteral obstruction (HP:0006000) | 2.63615216 |
| 45 | Alveolar cell carcinoma (HP:0006519) | 2.62904231 |
| 46 | Pulmonary embolism (HP:0002204) | 2.62525073 |
| 47 | Abnormality of the pleura (HP:0002103) | 2.58688953 |
| 48 | Type I transferrin isoform profile (HP:0003642) | 2.56147862 |
| 49 | Hemoptysis (HP:0002105) | 2.55570050 |
| 50 | IgM deficiency (HP:0002850) | 2.55445233 |
| 51 | Anhidrosis (HP:0000970) | 2.54217248 |
| 52 | Leukocytosis (HP:0001974) | 2.49451294 |
| 53 | Recurrent skin infections (HP:0001581) | 2.47512315 |
| 54 | Orchitis (HP:0100796) | 2.46409822 |
| 55 | Abnormality of T cell physiology (HP:0011840) | 2.45703913 |
| 56 | Carpal bone hypoplasia (HP:0001498) | 2.44915119 |
| 57 | Recurrent bacterial skin infections (HP:0005406) | 2.39660664 |
| 58 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.38754471 |
| 59 | Abnormal albumin level (HP:0012116) | 2.35175036 |
| 60 | Hypoalbuminemia (HP:0003073) | 2.35175036 |
| 61 | Genetic anticipation (HP:0003743) | 2.30932235 |
| 62 | Amyotrophic lateral sclerosis (HP:0007354) | 2.25449007 |
| 63 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.25359050 |
| 64 | Purpura (HP:0000979) | 2.22049049 |
| 65 | Bronchitis (HP:0012387) | 2.21326973 |
| 66 | Recurrent otitis media (HP:0000403) | 2.20517361 |
| 67 | Joint swelling (HP:0001386) | 2.11278343 |
| 68 | Dicarboxylic aciduria (HP:0003215) | 2.08158203 |
| 69 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.08158203 |
| 70 | Oral leukoplakia (HP:0002745) | 2.08142763 |
| 71 | Abnormality of male internal genitalia (HP:0000022) | 2.06800723 |
| 72 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.06752486 |
| 73 | Recurrent abscess formation (HP:0002722) | 2.03169745 |
| 74 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.03004949 |
| 75 | Keratoconjunctivitis sicca (HP:0001097) | 2.02280162 |
| 76 | Arthropathy (HP:0003040) | 2.02028436 |
| 77 | Spontaneous hematomas (HP:0007420) | 2.01134540 |
| 78 | Eosinophilia (HP:0001880) | 2.00147226 |
| 79 | Mediastinal lymphadenopathy (HP:0100721) | 1.98453777 |
| 80 | Increased IgM level (HP:0003496) | 1.97545972 |
| 81 | Abnormality of the pericardium (HP:0001697) | 1.95954573 |
| 82 | Pulmonary fibrosis (HP:0002206) | 1.94148739 |
| 83 | Polyneuropathy (HP:0001271) | 1.91346209 |
| 84 | Glomerulopathy (HP:0100820) | 1.89044665 |
| 85 | Poor speech (HP:0002465) | 1.87935569 |
| 86 | Bronchiectasis (HP:0002110) | 1.87725859 |
| 87 | Increased intramyocellular lipid droplets (HP:0012240) | 1.86370983 |
| 88 | Neoplasm of the heart (HP:0100544) | 1.84893712 |
| 89 | Keratoconjunctivitis (HP:0001096) | 1.84746838 |
| 90 | Lymphoma (HP:0002665) | 1.81046583 |
| 91 | Gaze-evoked nystagmus (HP:0000640) | 1.80427962 |
| 92 | Arterial thrombosis (HP:0004420) | 1.80318799 |
| 93 | Inflammation of the large intestine (HP:0002037) | 1.77727595 |
| 94 | Pustule (HP:0200039) | 1.77538710 |
| 95 | Hemiplegia (HP:0002301) | 1.77036824 |
| 96 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.76482499 |
| 97 | Glucose intolerance (HP:0000833) | 1.75446275 |
| 98 | Self-mutilation (HP:0000742) | 1.75025652 |
| 99 | Abnormality of the columella (HP:0009929) | 1.73268244 |
| 100 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.73152423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 8.44707540 |
| 2 | SCYL2 | 5.01674368 |
| 3 | KDR | 4.43621787 |
| 4 | PIK3CG | 4.03034572 |
| 5 | MAP4K1 | 2.71025389 |
| 6 | FES | 2.62756289 |
| 7 | TESK2 | 2.53445432 |
| 8 | ITK | 2.41544196 |
| 9 | CAMKK2 | 2.37245303 |
| 10 | MST4 | 1.91685444 |
| 11 | TAOK3 | 1.87861924 |
| 12 | ZAP70 | 1.87664573 |
| 13 | MATK | 1.87044542 |
| 14 | NTRK1 | 1.86937752 |
| 15 | TNK2 | 1.73214647 |
| 16 | BLK | 1.66344941 |
| 17 | IKBKE | 1.60618900 |
| 18 | SYK | 1.60209578 |
| 19 | CSK | 1.57373457 |
| 20 | BTK | 1.57236510 |
| 21 | RIPK4 | 1.52439809 |
| 22 | LCK | 1.45835845 |
| 23 | BRSK2 | 1.43463018 |
| 24 | GRK6 | 1.41278050 |
| 25 | MAP3K9 | 1.36191194 |
| 26 | EIF2AK3 | 1.33995998 |
| 27 | ARAF | 1.27806478 |
| 28 | TYRO3 | 1.19841686 |
| 29 | MAP3K13 | 1.15760258 |
| 30 | LYN | 1.13339886 |
| 31 | CSF1R | 1.10269844 |
| 32 | PRKCQ | 1.08777838 |
| 33 | TBK1 | 0.99057391 |
| 34 | TESK1 | 0.98995848 |
| 35 | TEC | 0.98779925 |
| 36 | IKBKB | 0.97511286 |
| 37 | ADRBK2 | 0.93721930 |
| 38 | MAP3K12 | 0.91185308 |
| 39 | CAMKK1 | 0.86014286 |
| 40 | VRK1 | 0.85882758 |
| 41 | MAPKAPK3 | 0.83297768 |
| 42 | PIM1 | 0.82941527 |
| 43 | FRK | 0.80615193 |
| 44 | STK4 | 0.79531822 |
| 45 | CDK4 | 0.75468315 |
| 46 | HCK | 0.69161119 |
| 47 | NEK6 | 0.64189117 |
| 48 | FYN | 0.61516830 |
| 49 | TLK1 | 0.61026239 |
| 50 | MYLK | 0.60597229 |
| 51 | MARK3 | 0.60406400 |
| 52 | PIM2 | 0.59519326 |
| 53 | ERBB2 | 0.59144191 |
| 54 | JAK3 | 0.57328119 |
| 55 | AURKA | 0.56175967 |
| 56 | BMPR2 | 0.56005459 |
| 57 | STK11 | 0.55861780 |
| 58 | MAP2K6 | 0.55471589 |
| 59 | FGR | 0.53074047 |
| 60 | OBSCN | 0.51768894 |
| 61 | GRK5 | 0.51636185 |
| 62 | ATR | 0.50934274 |
| 63 | PDGFRB | 0.41806979 |
| 64 | FGFR1 | 0.40934842 |
| 65 | IGF1R | 0.39671596 |
| 66 | JAK2 | 0.36756045 |
| 67 | BUB1 | 0.35415525 |
| 68 | MAP3K11 | 0.35000202 |
| 69 | LRRK2 | 0.33757888 |
| 70 | TYK2 | 0.33466193 |
| 71 | STK24 | 0.32521194 |
| 72 | INSR | 0.32154441 |
| 73 | INSRR | 0.30277767 |
| 74 | LIMK1 | 0.29503310 |
| 75 | CAMK4 | 0.28591491 |
| 76 | RPS6KA5 | 0.27322941 |
| 77 | EGFR | 0.26890677 |
| 78 | PDK1 | 0.26289144 |
| 79 | DAPK3 | 0.25802701 |
| 80 | AURKB | 0.25742237 |
| 81 | ROCK1 | 0.25507440 |
| 82 | MAP3K2 | 0.25079510 |
| 83 | MAP3K14 | 0.24592714 |
| 84 | VRK2 | 0.24509745 |
| 85 | TIE1 | 0.23429764 |
| 86 | GRK7 | 0.23324731 |
| 87 | BRSK1 | 0.22654633 |
| 88 | FLT3 | 0.22281217 |
| 89 | PRKD1 | 0.22093618 |
| 90 | BCKDK | 0.21450454 |
| 91 | NUAK1 | 0.21368557 |
| 92 | PRKCB | 0.21122774 |
| 93 | MAPK11 | 0.20882241 |
| 94 | DYRK1A | 0.20718857 |
| 95 | GRK1 | 0.20711981 |
| 96 | MAPKAPK2 | 0.20677815 |
| 97 | CAMK2A | 0.19381383 |
| 98 | NLK | 0.19067540 |
| 99 | JAK1 | 0.18855714 |
| 100 | RAF1 | 0.18622574 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.76415045 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.82007458 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.38652988 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.19373927 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.18963173 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.10154171 |
| 7 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 3.01474543 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.87084803 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.80910083 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.55607755 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.13811037 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.11285967 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.97742818 |
| 14 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.92627472 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.68189075 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.65837172 |
| 17 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.61802549 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.60864470 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.58570250 |
| 20 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.57790070 |
| 21 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.56866340 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.47904000 |
| 23 | Shigellosis_Homo sapiens_hsa05131 | 1.47357786 |
| 24 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.40011959 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.38009064 |
| 26 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.33976984 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32538735 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.28994717 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.25397631 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.23287482 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.22667922 |
| 32 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.15240956 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.10751072 |
| 34 | Alcoholism_Homo sapiens_hsa05034 | 1.09551053 |
| 35 | Homologous recombination_Homo sapiens_hsa03440 | 1.05315381 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.05281180 |
| 37 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01081871 |
| 38 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99614702 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.97146148 |
| 40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.95003329 |
| 41 | Protein export_Homo sapiens_hsa03060 | 0.88113673 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.86787770 |
| 43 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86703422 |
| 44 | Ribosome_Homo sapiens_hsa03010 | 0.85996064 |
| 45 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.84501116 |
| 46 | Prion diseases_Homo sapiens_hsa05020 | 0.81104087 |
| 47 | Alzheimers disease_Homo sapiens_hsa05010 | 0.78836449 |
| 48 | Asthma_Homo sapiens_hsa05310 | 0.77809958 |
| 49 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75603366 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.75532846 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72824039 |
| 52 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70394297 |
| 53 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.67422142 |
| 54 | Leishmaniasis_Homo sapiens_hsa05140 | 0.66976101 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63709755 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 0.63157677 |
| 57 | Apoptosis_Homo sapiens_hsa04210 | 0.62926004 |
| 58 | Influenza A_Homo sapiens_hsa05164 | 0.51842272 |
| 59 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.51345080 |
| 60 | RNA degradation_Homo sapiens_hsa03018 | 0.47487384 |
| 61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44000469 |
| 62 | Mismatch repair_Homo sapiens_hsa03430 | 0.43976724 |
| 63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42590765 |
| 64 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42374493 |
| 65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.42231489 |
| 66 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.42228301 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42014932 |
| 68 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41684733 |
| 69 | Morphine addiction_Homo sapiens_hsa05032 | 0.39277664 |
| 70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.37556589 |
| 71 | Tuberculosis_Homo sapiens_hsa05152 | 0.37334611 |
| 72 | Huntingtons disease_Homo sapiens_hsa05016 | 0.36415269 |
| 73 | Phototransduction_Homo sapiens_hsa04744 | 0.36356994 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35734293 |
| 75 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34940581 |
| 76 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.34694172 |
| 77 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.33315282 |
| 78 | Malaria_Homo sapiens_hsa05144 | 0.32112240 |
| 79 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.28370905 |
| 80 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.28087992 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.27135493 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.26362853 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25669324 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.24270688 |
| 85 | RNA polymerase_Homo sapiens_hsa03020 | 0.23839958 |
| 86 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.23817239 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.23587351 |
| 88 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23569435 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.22365141 |
| 90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.21455714 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.20473903 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.19817322 |
| 93 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.16459024 |
| 94 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.14794399 |
| 95 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.14284997 |
| 96 | GABAergic synapse_Homo sapiens_hsa04727 | 0.12926479 |
| 97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.12847775 |
| 98 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.10631476 |
| 99 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.07371139 |
| 100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.05442355 |

